Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04020185 |
| Title | Safety and Efficacy Study of IMSA101 in Refractory Malignancies |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | ImmuneSensor Therapeutics Inc. |
| Indications |
progesterone-receptor negative breast cancer |
| Therapies |
IMSA101 + unspecified PD-L1 antibody |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Honor Health | Recruiting | Scottsdale | Arizona | 85260 | United States | Details |
| UC San Diego Moores Cancer Center | Recruiting | La Jolla | California | 92093 | United States | Details |
| Northwestern University | Recruiting | Chicago | Illinois | 60611 | United States | Details |
| Atlantic Health System/Morristown Medical Center | Recruiting | Morristown | New Jersey | 07962 | United States | Details |
| UT Southwestern | Recruiting | Dallas | Texas | 75390 | United States | Details |
| MD Anderson Cancer Center | Recruiting | Houston | Texas | 77030 | United States | Details |